In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Suddenbreakingnews Now 'Official Ridgling'
- The Art of Exaggerator's Stud Deal
- Songbird Works at Santa Anita, Target Unknown
- Exaggerator Arrives at Belmont Park
- Si Sage Speeds to Whittingham Victory
- Leroidesanimaux Dies at 16
- California Chrome 'Stronger' in Los Al Drill
- Lexie Lou Back to Winning Ways at Woodbine
- Makahiki Wins Japanese Derby
- Royal Ascot Journey Confirmed for Tepin